IC
AVNR

Intersect Capital’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Intersect Capital’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-25
Closed – – 518
2014
Q4 		$0 Buy
+25
New +$352 ﹤0.01% 457

Intersect Capital's AVNR Position: Q1 2015 in Review

Intersect Capital sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 25 shares.

Intersect Capital first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $0 in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Intersect Capital reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Intersect Capital sold 25 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015.
  • Intersect Capital first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • Intersect Capital's AVANIR PHARMACEUTICALS, INC CL A position peaked at $0 in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Intersect Capital's 13F filing for Q1 2015, filed 11 May 2015.